ZCA
PRPH

Zeke Capital Advisors’s ProPhase Labs PRPH Stock Holding History

Zeke Capital Advisors’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,500
Closed -$259K – 352
2021
Q1 		$259K Buy
+3,500
New +$336K 0.02% 240

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
KSCM
Kamunting Street Capital Management Miami Beach, Florida $179M AUM 5.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Zeke Capital Advisors's PRPH Position: Q2 2021 in Review

Zeke Capital Advisors sold out of ProPhase Labs (PRPH) in Q2 2021, closing a stake of 3,500 shares — an estimated $259K sold.

Zeke Capital Advisors first reported a position in PRPH in Q1 2021 and held it in 1 quarter. The position peaked at $259K in Q1 2021. 23 funds tracked by Wall St. Rank hold PRPH as of Q2 2021.

  • Zeke Capital Advisors reported no remaining ProPhase Labs position as of Q2 2021 after selling out during the quarter.
  • Zeke Capital Advisors sold 3,500 ProPhase Labs shares in Q2 2021, an estimated $259K.
  • Zeke Capital Advisors first reported a position in ProPhase Labs in Q1 2021 and held it in 1 quarter.
  • Zeke Capital Advisors's ProPhase Labs position peaked at $259K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held ProPhase Labs as of Q2 2021.

Based on Zeke Capital Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.